Chondrosteo+ Tablets
In stock
Description
WELLNESS AND JOINT MOBILITY
Joint dysfunction (knees, hips, back, ankles, shoulders, wrists, ...) can occur at any period in life, resulting in unpleasant sensations all over the body. Over the years, due to a sportive activity, seasonal changes, or simply due to a poor posture, joints ultimately weaken. In order to preserve your mobility and stay in shape, CHONDROSTEO+® is the ideal overall brand to help you achieve that.
The Laboratoire des Granions® has thouroughly developed a triple action formula to exclusively act on your joints. CHONDROSTEO+® contains 10 carefully selected ingredients which are the following:
- Glucosamine HCL with a dosage of 1125 mg.
- Chondroitin sulfate with a dosage of 150 mg.
- Harpagophytum which has traditionally been used to enhance joint comfort.
- Methylsulfonylmethane (MSM) containing sulfur.
- Blackcurrant leaves and meadowsweet both contribute to improving joint mobility.
- Minerals and trace elements: calcium and manganese help fortify the bones; bamboo extract with silica content and copper both contribute to maintaining the connective tissues, and particularly the cartilage.
More Information
Ingredients
Ingredients:
Usage tips:
Take 3 tablets at once with a full glass of water during breakfast. Repeat the 3-month program if necessary.
Duration of the program:
CHONDROSTEO 40 tablets: 2-week program
CHONDROSTEO 90 tablets: 1-month program
CHONDROSTEO 120 tablets: 6-week program
CHONDROSTEO 180 tablets: 2-month program
Precautions for use:
Do not exceed the recommended dose.
It is advisable to consume this supplement as part of a varied and balanced diet and a healthy lifestyle.
Keep out of reach of young children.
Not recommended for people allergic to salicyliates, under anticoagulant therapy, children or teenagers due to the presence of meadowsweet. Calcium can cause kidney problems for people at higher risk (harpagophytum).
This nutritional supplement is not a drug.
Storage:
Keep away from heat and humidity.
Consume preferably before the date indicated on the case.
This product has been developed and manufactured in accordance with the requirements of EN 17444 as of the production date of the batch. Compliance with the standard refers to the implementation of good development and manufacturing practices aimed at preventing the presence of prohibited substances but does not guarantee the absence of such substances. The standard does not constitute approval for use for those subject to anti-doping control.
Reviews: Chondrosteo+ Tablets
We found other products you might like!
-
Collagène type II (non dénaturé)
-
Breveté UCC-II®
Out of stock